Free T4 (thyroxine)
Thyroid · specimen: blood
Also called: free thyroxine, FT4, T4 free absolute, thyroxine free
Chart note
Pick Ordered or Not ordered to see the note.
Indicated when
- Confirming and characterizing an abnormal TSH, in the same sample as the repeat TSH [1, 2]
- Suspected secondary (pituitary or hypothalamic) hypothyroidism, ordered together with TSH, because TSH itself becomes unreliable in that situation [1]
- Monitoring and adjusting therapy in a patient with confirmed secondary hypothyroidism, where TSH cannot be used to guide dosing [1]
Not indicated when
- As a stand-alone screening test without a TSH [2, 1]
- Routine monitoring or levothyroxine dose adjustment in a patient with known primary hypothyroidism: current Canadian guidance is to use TSH alone for this [3]
Why not
Free T4 can be affected by non-thyroidal illness, pregnancy, and assay differences between labs, so an isolated result without a TSH for context is harder to interpret. In known primary hypothyroidism, TSH already reflects the pituitary's fine-grained response to circulating thyroid hormone, so current Canadian guidance holds that adding free T4 to routine monitoring doesn't change management, only cost and the chance of a discordant, confusing result [3].
Better first step
Order TSH first; add free T4 to the same sample only if the TSH is abnormal, or if secondary (pituitary) disease is suspected, in which case order both together from the start [1, 2].
Typical ND rationale
An ND commonly includes free T4 alongside TSH from the start, reasoning that TSH alone can miss secondary (pituitary) hypothyroidism and that seeing the actual circulating hormone level gives a fuller picture than TSH alone.
Where the ND is right
The ND is right that TSH alone is not enough when secondary (pituitary) hypothyroidism is suspected: free T4 is genuinely needed there, because TSH itself becomes unreliable. Free T4 is also correctly the next step whenever a TSH comes back abnormal [1].
Ontario coverage & CONO orderability
- OHIP status
- unverified
- Free T4 is listed by name in the 2026 Schedule (L339, 'T-4, free absolute'), but unlike TSH (L341, $3.58) and free T3 (L607, $3.53), it carries a listed professional fee of $0.00. What that $0.00 fee means for physician-ordered billing (bundled into another code, technical-fee-only, or otherwise) could not be established from the Schedule text itself, so coverage is recorded as unverified rather than assumed insured. ND-ordered testing is patient-paid regardless (Reg. 552 s.22).
- CONO orderable
- Yes — CONO list #120
- CONO list item 120, blood: 'Thyroxine Free (FT4).'
Linked conditions
Counselling script
“Free T4 is a follow-up test, not a stand-alone one, so I order it together with TSH rather than by itself. If your TSH is normal and there are no signs of a pituitary problem, adding free T4 doesn't tell us anything more. If your TSH does come back abnormal, or if I ever suspect a pituitary cause, I'll order free T4 in the same sample right away.”
Revisit if
- TSH result comes back abnormal
- New symptoms suggesting pituitary disease (headache, visual field change, other hormone symptoms)
- Known secondary hypothyroidism with a change in symptoms or medication dose
References
- [1]National Institute for Health and Care Excellence (NICE) (2019). Thyroid disease: assessment and management (NG145). linkFree T4 is measured alongside TSH to confirm an abnormal result, and TSH plus FT4 are ordered together when secondary hypothyroidism is suspected
- [2]Ontario Association of Medical Laboratories (OAML) (2007). Guideline for the Use of Laboratory Tests to Detect Thyroid Dysfunction (CLP 015). linkolder guidelinesTSH alone is the appropriate initial test; free thyroid hormone levels confirm and further investigate an abnormal result
- [3]Canadian Society of Endocrinology and Metabolism / Choosing Wisely Canada (2026). Endocrinology and Metabolism: Seven Tests and Treatments to Question. linkDon't use free T4 or T3 to screen for hypothyroidism or to monitor and adjust levothyroxine dose in patients with known primary hypothyroidism
Evidence notes
There is a real tension between the 2007 OAML guideline, which recommends checking free T4 and free T3 4-6 weeks after any dose change (for both hypo- and hyperthyroid monitoring), and the current (2026) Choosing Wisely Canada endocrinology recommendation, which says not to use free T4 or T3 to monitor and adjust levothyroxine dose in known primary hypothyroidism. The more recent, Canadian, specialty-society source is given more weight here, and OAML's older monitoring advice is flagged as superseded in practice rather than cited for that specific claim. The $0.00 Schedule fee for free T4 (L339) versus a real fee for free T3 (L607) is an unexplained asymmetry; flagged for the reviewer rather than guessed at.